| Literature DB >> 29201018 |
Sabina Davidsson1, Jessica Carlsson1, Paula Mölling2, Natyra Gashi1, Ove Andrén1, Swen-Olof Andersson1, Elzbieta Brzuszkiewicz3, Anja Poehlein3, Munir A Al-Zeer4, Volker Brinkmann5, Carsten Scavenius6, Seven Nazipi7, Bo Söderquist2, Holger Brüggemann7.
Abstract
Inflammation is one of the hallmarks of prostate cancer. The origin of inflammation is unknown, but microbial infections are suspected to play a role. In previous studies, the Gram-positive, low virulent bacterium Cutibacterium (formerly Propionibacterium) acnes was frequently isolated from prostatic tissue. It is unclear if the presence of the bacterium represents a true infection or a contamination. Here we investigated Cutibacterium acnes type II, also called subspecies defendens, which is the most prevalent type among prostatic C. acnes isolates. Genome sequencing of type II isolates identified large plasmids in several genomes. The plasmids are highly similar to previously identified linear plasmids of type I C. acnes strains associated with acne vulgaris. A PCR-based analysis revealed that 28.4% (21 out of 74) of all type II strains isolated from cancerous prostates carry a plasmid. The plasmid shows signatures for conjugative transfer. In addition, it contains a gene locus for tight adherence (tad) that is predicted to encode adhesive Flp (fimbrial low-molecular weight protein) pili. In subsequent experiments a tad locus-encoded putative pilin subunit was identified in the surface-exposed protein fraction of plasmid-positive C. acnes type II strains by mass spectrometry, indicating that the tad locus is functional. Additional plasmid-encoded proteins were detected in the secreted protein fraction, including two signal peptide-harboring proteins; the corresponding genes are specific for type II C. acnes, thus lacking from plasmid-positive type I C. acnes strains. Further support for the presence of Flp pili in C. acnes type II was provided by electron microscopy, revealing cell appendages in tad locus-positive strains. Our study provides new insight in the most prevalent prostatic subspecies of C. acnes, subsp. defendens, and indicates the existence of Flp pili in plasmid-positive strains. Such pili may support colonization and persistent infection of human prostates by C. acnes.Entities:
Keywords: Cutibacterium acnes; Propionibacterium acnes; fimbrial low-molecular weight protein; pili; plasmid; prostate cancer; tight adherence
Year: 2017 PMID: 29201018 PMCID: PMC5696575 DOI: 10.3389/fmicb.2017.02241
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Amplification of tadA, indicative of the presence of a large plasmid in prostatic C. acnes isolates.
| Total number | |||
|---|---|---|---|
| All types | 37 (20) | 144 (80) | 181 |
| Type IA | 8 (15) | 45 (85) | 53 |
| Type IB | 7 (21) | 27 (79) | 34 |
| Type II | 22 (26) | 62 (74) | 84 |
| Type III | 0 (0) | 10 (100) | 10 |
Distribution of tadA-positive (+) and -negative (-) C. acnes strains among isolates obtained from prostate cancer (PCa) cases and controls.
| Type IA | Type IB | Type II | ||||
|---|---|---|---|---|---|---|
| + | - | + | - | + | - | |
| PCa cases | 4 | 33 | 3 | 16 | 21 | 47 |
| Controls | 3 | 2 | 1 | 2 | 1 | 9 |
| Controls with PCa | 1 | 10 | 3 | 9 | 0 | 6 |
Features of sequenced C. acnes isolates and their large plasmids.
| Strain | Source | Phylo-type | SLST type | Genome size (kb) | Contigs | Plasmid size (bp) | Plasmid GC content (%) | CRISPR/cas (# spacers) |
|---|---|---|---|---|---|---|---|---|
| 12-89 | Healthy | IA1 | A1 | 2480 | 9 | – | – | No |
| 11-78 | Tumor | IA1 | A1 | 2528 | 15 | 54033 | 62.4 | No |
| 09-263 | Tumor | IA1 | A1 | 2484 | 14 | – | – | No |
| 10-113 | Healthy | IA1 | C5 | 2527 | 15 | 47433 | 62.9 | No |
| 10-167 | Tumor | IA1 | A1 | 2525 | 11 | few gaps | 62.5 | No |
| 10-118 | Healthy | IA1 | A1 | 2475 | 13 | – | – | No |
| 11-88 | Tumor | IB | H1 | 2545 | 14 | – | – | No |
| 11-90 | Tumor | IB | H1 | 2597 | 15 | 53358 | 62.4 | No |
| 09-9 | Tumor | II | K1 | 2532 | 16 | 53137 | 63.0 | Yes (1) |
| 09-23 | Healthy | II | K1 | 2476 | 12 | – | – | Yes (3) |
| 09-323 | Tumor | II | K8 | 2537 | 11 | 53582 | 62.9 | Yes (2) |
| 10-482 | Healthy | II | K8 | 2541 | 12 | 57860 | 61.7 | Yes (1) |
| 10-43 | Tumor | II | K2 | 2565 | 79 | 56106 | 62.7 | Yes (6) |
| 11-79 | Tumor | II | K2 | 2539 | 8 | 54149 | 62.9 | Yes (2) |
| 11-356 | Tumor | II | K2 | 2521 | 36 | – | – | Yes (2) |
| 09-109 | Tumor | II | K5 | 2538 | 11 | 53516 | 63.0 | Yes (1) |
| 11-49 | Tumor | II | K1 | 2540 | 17 | Few gaps | 63.0 | Yes (3) |
Identification of plasmid-encoded proteins in secreted and surface sheared fractions of two C. acnes strains.
| Strain | Fraction | Locus ID (in p09-9) | Annotation | MW | Score | Significant matches | Coverage (%) | Unique peptides |
|---|---|---|---|---|---|---|---|---|
| 11-79 | Secretome | APS60_12543 | PT repeat protein, partial FlhF domain (type II specific) | 62.5 | 577 | 15 | 20.8 | 11 |
| 11-79 | Secretome | APS60_12625 | Hypothetical protein, signal peptide | 30.7 | 520 | 12 | 27 | 6 |
| 11-79 | Secretome | APS60_12535 | 34.5 | 200 | 6 | 20.5 | 5 | |
| 11-79 | Secretome | APS60_12600 | TadE family protein (TadE2) | 12.9 | 119 | 2 | 26.4 | 2 |
| 11-79 | Sheared | APS60_12625 | Hypothetical protein, signal peptide | 30.7 | 1009 | 19 | 39.2 | 8 |
| 11-79 | Sheared | APS60_12543 | PT repeat protein, partial FlhF domain (type II specific) | 62.5 | 823 | 22 | 19.6 | 12 |
| 11-79 | Sheared | APS60_12600 | TadE family protein (TadE2) | 12.9 | 242 | 4 | 26.4 | 2 |
| 11-79 | Sheared | APS60_12535 | 34.5 | 145 | 6 | 14.4 | 4 | |
| 09-9 | Secretome | APS60_12625 | Hypothetical protein, signal peptide | 30.7 | 455 | 12 | 27 | 6 |
| 09-9 | Secretome | APS60_12600 | TadE family protein (TadE2) | 12.9 | 213 | 4 | 44.8 | 3 |
| 09-9 | Sheared | APS60_12625 | Hypothetical protein, signal peptide | 30.7 | 895 | 21 | 47.8 | 9 |
| 09-9 | Sheared | APS60_12600 | TadE family protein (TadE2) | 12.9 | 593 | 11 | 44.8 | 3 |